Home › Research › Inflammation and the immune system
Efficacy of Dang Gui Shao Yao San in treating vascular dementia in animal models: a systematic review and meta-analysis
Qu G, Bi Y, Wang L, Xu L, Zhang Y, Ma Y, Tian C, Zhang Z.. Frontiers in aging neuroscience, 2026-03-13
Topic: Risk, prevention and care in population studies
Plain-language summary
Animal studies indicate that Dang Gui Shao Yao San (DGSYS) may enhance cognitive function in VaD models through mechanisms such as antioxidation and the enhancement of cerebral blood flow. Results Seven studies involving 420 rats and mice were included. Specifically, DGSYS significantly improved spatial learning and memory performance, as assessed by the Morris water maze, and attenuated oxidative stress-related pathological changes. Overall, the available evidence suggests potential neuroprotective effects of DGSYS in preclinical models, warranting further standardized and rigorously designed studies before clinical translation can be considered.
What this study adds
Evidence grade: High
This is a pooled review. Pooling seven studies with 420 rats and mice, this review found that Dang Gui Shao Yao San, a traditional herbal formula, improved spatial learning and memory in animal models of vascular dementia and reduced oxidative stress damage. Because all the evidence comes from animals, the authors say better-designed studies are needed before testing it in people.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Qu, G., Bi, Y., Wang, L., Xu, L., Zhang, Y., Ma, Y., et al. (2026). Efficacy of Dang Gui Shao Yao San in treating vascular dementia in animal models: a systematic review and meta-analysis. Frontiers in aging neuroscience. https://doi.org/10.3389/fnagi.2026.1701536
Vancouver
Qu G, Bi Y, Wang L, Xu L, Zhang Y, Ma Y, et al. Efficacy of Dang Gui Shao Yao San in treating vascular dementia in animal models: a systematic review and meta-analysis. Frontiers in aging neuroscience. 2026. doi:10.3389/fnagi.2026.1701536. PMID: 41907844.
BibTeX
@article{qu2026-41907844,
author = {Qu, G. and Bi, Y. and Wang, L. and Xu, L. and Zhang, Y. and Ma, Y. and Tian, C. and Zhang, Z.},
title = {{Efficacy of Dang Gui Shao Yao San in treating vascular dementia in animal models: a systematic review and meta-analysis}},
journal = {Frontiers in aging neuroscience},
year = {2026},
doi = {10.3389/fnagi.2026.1701536},
pmid = {41907844},
url = {https://doi.org/10.3389/fnagi.2026.1701536}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 8 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- Animal studies indicate that Dang Gui Shao Yao San (DGSYS) may enhance cognitive function in VaD models through mechanisms such as antioxidation and the enhancement of cerebral blood flow.
- Results Seven studies involving 420 rats and mice were included.
- Specifically, DGSYS significantly improved spatial learning and memory performance, as assessed by the Morris water maze, and attenuated oxidative stress-related pathological changes.
- Overall, the available evidence suggests potential neuroprotective effects of DGSYS in preclinical models, warranting further standardized and rigorously designed studies before clinical translation can be considered.
Why it matters
Pooling seven studies with 420 rats and mice, this review found that Dang Gui Shao Yao San, a traditional herbal formula, improved spatial learning and memory in animal models of vascular dementia and reduced oxidative stress damage. Because all the evidence comes from animals, the authors say better-designed studies are needed before testing it in people.
Study details
- Study designsystematic review
- Evidence strengthHigh
How this study scored 48/100
Published in a peer-reviewed journal, and it is a systematic review of all the studies on the question. Scored zero for sample size, effect reported and studied in people because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 46 of the 96 points we could judge it on, which is 48 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Frontiers in aging neuroscience) |
| Journal's citation record | 2 / 4 | Frontiers in Aging Neuroscience: journal h-index 174 (OpenAlex, 2026-10-29) |
| Study design | 12 / 12 | A systematic review of all the studies on the question |
| Strength of evidence | 5 / 5 | Rated “high” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | A review of other studies — randomization is not credited here |
| Times cited | 0 / 7 | Cited 0 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.0 citations a year over 2 year(s) since 2026 |
| Impact for its field and year | 0 / 6 | Cited 0.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | — / 4 | OpenAlex's profile for last-listed author Zhe Zhang holds only 1 work(s), too few to judge a track record — left out of this score |
| Institution's track record | 0 / 3 | Macau University of Science and Technology: institution h-index 292 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41907844) |
| Free to read | 2 / 2 | Free to read |
| Points | 46 / 96 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 46 of the 96 points we could judge it on is 48 out of 100. |
| Total | 48 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.3389/fnagi.2026.1701536
- PubMed: 41907844
- Original source →
- Free full text: Frontiers in Aging Neuroscience →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Inflammation and the immune system from nearby years
Also tagged “trial”
783 studies in the library carry the topic tag “trial”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 783 tagged studies.